GlassScriptPhysician profile
Seth Aaron Stambaugh
NPI 1730706219
$707.67
in general payments reported to CMS, 2019-2025
16 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.49 · 2021: $98.46 · 2022: $33.50 · 2023: $132 · 2024: $262 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $109.98 | 2023-2024 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $103.37 | 2023-2025 | Ubrelvy |
| Novo Nordisk INC | $79.70 | 2024-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $66.62 | 2020-2023 | Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $52.64 | 2021 | |
| Amgen INC. | $52.28 | 2023-2025 | Otezla, Repatha, Repatha |
| Organon LLC | $46.40 | 2021-2023 | Nexplanon |
| Neurocrine Biosciences, INC. | $32.52 | 2023-2024 | Ingrezza |
| Medtronic, INC. | $29.03 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Axsome Therapeutics, INC. | $23.85 | 2024 | Auvelity |
| Lundbeck LLC | $22.96 | 2025 | Abilify Asimtufii |
| Alkermes, INC. | $21.63 | 2025 | Lybalvi |
| Eisai INC. | $20.70 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $17.55 | 2021 | |
| Exact Sciences Corporation | $16.55 | 2023 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Stambaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.